钩藤碱对心血管系统部分药理作用研究

探讨钩藤碱对钙离子的拮抗作用以及对脑血流量和氧消耗的作用。方法观察钩藤碱对豚鼠心肌的兴奋性、功能性不应期、正阶梯现象的作用，以及对去甲肾上腺素诱发的兔主动脉条Ⅰ、Ⅱ相收缩的作用，同时观察钩藤碱对小鼠氧消耗和大鼠脑血流量的影响。结果钩藤碱能提高心肌兴奋性，延长功能性不应期，抑制正阶梯现象和兔主动脉条Ⅰ、Ⅱ相收缩；减慢小鼠氧消耗速度，对大鼠脑血流量无影响。结论钩藤碱具有许多钙拮抗剂的共同特点，提示其在抗心律失常方面会有一定作用。     

延髓腹外侧区在调节呼吸和心血管系统中的作用

现已知延髓腹外侧区在呼吸调节和心血管调节中起着重要作用．延髓腹外侧区有两个重要的血管运动中枢，称为头侧和尾侧血管运动中枢．参与呼吸调节的中枢化学感受器位于延髓腹外侧区浅表部位；延髓腹外侧区还参与中枢和外周化学感受器的传入冲动的整合．文章对一些最重要的有争论的观点作一综述     

心血管外科术后急性肾功能衰竭的处理

目的：总结两组心血管外科术后急性肾功能衰竭病例的治疗经验，提出心血管外科术后急性肾功能衰竭的特点、早期诊断标准及处理原则。方法：１７例心血管外科术后急性肾功能衰竭病例，以入院先后分为两组。第１组８例，第２组９例。回顾第１组病例的急性肾功能衰竭的治疗经验，总结腹膜透析、血液透析和血液滤过的优缺点。在第２组病例治疗中，以急性肾功能衰竭的早期诊断为前题，早期开始腹膜透析。同时，强调综合治疗的重要性。结果：第１组病例均死亡。第２组病例，７例存活（７８％）。结论：心血管外科术后急性肾功能衰竭的早期诊断和早期肾功能替代疗法，是治疗成败的关键。腹膜透析简便易行，在急性肾功能衰竭的早期开始腹膜透析，可以收到良好效果，并以此作为心血管外科术后急性肾功能衰竭的首选肾功能替代疗法。     

μ,δ,κ阿片受体在创伤失血性休克大鼠心血管功能抑制中的作用

目的探讨μ，δ和κ阿片受体与创伤失血性休克大鼠心血管功能抑制的关系。方法用大鼠创伤失血性休克模型，观察创伤失血性休克后大鼠心脏和脑μ，δ和κ阿片受体变化及其与血流动力学指标的变化的关系；观察δ和κ阿片受体特异性拮抗剂对创伤失血性休克大鼠血流动力学指标的影响。结果创伤失血性休克后，大鼠心脏和脑δ和κ阿片受体数目明显升高，亲和力无明显变化，心脏和脑的δ和κ阿片受体数目升高与创伤失血性休克后大鼠血流动力学指标下降呈显著负相关。δ和κ阿片受体特异性拮抗剂可明显逆转创伤失血性休克大鼠血流动力学指标的下降。结论δ和κ阿片受体在创伤失血性休克心血管功能抑制中起重要作用，参与了创伤失血性休克的发病过程     

Abnormal Digital Pressure Measurements in Diabetic Neuropathic Foot Ulceration

The diabetic neuropathic ulcer is typically slow to heal and recurrent. Macrovascular insufficiency is usually excluded as foot pulses are present and ankle:brachial pressure ratios are not decreased. These assessments cannot however exclude more distal vascular disease. Digital pressure measurements enable a reliable assessment of the distal peripheral vascular status to be made. The aim of this study was therefore to use toe pressures to assess the contribution of distal ischaemia in the pathogenesis of the neuropathic ulcer. Sixteen diabetic patients with recurrent neuropathic foot ulceration had their toe pressures compared to 10 neuropathic patients without a history of foot ulceration, 10 diabetic control subjects, and 11 normal subjects. Four non-diabetic patients with neuropathy and foot ulceration were also assessed. All subjects had ankle:brachial pressure indices ≧ 1. Toe pressure was assessed using laser Doppler flowmetry to record the return of skin blood flow. The toe:brachial pressure index (TBI) was then calculated. The diabetic patients with a history of recurrent neuropathic ulceration, had the lowest mean TBI, 0.63 ± 0.14 (SD), compared to the non-ulcerated diabetic neuropathy patients, the diabetic control subjects, and the normal subjects. 0.84 ± 0.11, 0.82 ± 0.1, and 0.81 ± 0.07, p < 0.01, respectively. Three of the four non-diabetic patients with neuropathic foot ulceration also had an abnormally low TBI. Reduced toe pressure measurements are thus found to be associated with neuropathic foot ulceration. The contribution of distal ischaemia in the pathogenesis of the diabetic neuropathic foot ulcer needs to be evaluated. One hundred and eight non-insulin-dependent diabetic patients who had been tested for autonomic dysfunction in 1984/85 were re-evaluated 5 years later. Autonomic function was assessed by means of four cardiovascular tests (heart rate variation during deep breathing and standing, and blood pressure variation after standing and sustained handgrip). Eighteen subjects were lost to follow-up; in the 90 patients who completed the study, both the deep breathing and the handgrip test significantly worsened (respectively from 13.7 ± 7.8 to 11.6 ± 6.3 beats min^?1 p < 0.01, and from 16.9 ± 8.2 to 12.7 ± 7.1 mmHg, p < 0.001), whereas both the 30:15 ratio and the variation of blood pressure on standing did not change. The impairment of a comprehensive evaluation score (from 2.5 ± 1.7 to 3.0 ± 1.5; p < 0.05) also confirmed the gradual deterioration of autonomic function over the study period.     

心房颤动治疗的未来发展方向——混合消融

心房颤动是临床常见的心律失常,已有研究证明其与严重不良心脑血管事件(心力衰竭、脑卒中和心肌梗死)有关,目前全球心房颤动的患病人数超过了3 300万,预计未来40年内其患病率将增加1倍以上。多年来,医学相关人员在探究心房颤动的病理生理机制及开创改进其治疗方法等方面付出了大量努力。目前心房颤动的治疗管理仍是临床医学上的一个难题,尽管心房颤动治疗的手术消融和导管消融技术已逐渐趋于成熟,但对于心房颤动最佳的治疗方式、消融能量的选择尚无统一定论。导管消融通常需要多次手术且成功率低,而手术消融术后不良事件发生率较高。近年来,鉴于心脏外科医生和电生理学家之间的密切合作,结合导管及微创手术消融诞生了一种治疗心房颤动的新型策略——混合消融模式。混合消融克服了导管消融和微创手术消融的缺点,减少了不良结局,在治疗持续性心房颤动,尤其是长期持续性心房颤动上取得了可观的成效。本文主要通过回顾心房颤动消融的研究进展,对比分析目前混合消融模式治疗心房颤动的现有研究成果,归纳总结这种新型心房颤动治疗策略的优势与挑战,以期为临床心房颤动的治疗提供更多选择。     

达格列净对2型糖尿病合并慢性心力衰竭患者微小RNA-423-5p的调控作用及心功能的影响研究

背景 糖尿病合并心力衰竭的患者数量庞大,达格列净作为新型降糖药物,目前已被指南推荐用于心力衰竭的治疗,但其改善心功能的作用机制还未完全明确。目的 研究达格列净对2型糖尿病（T2DM）合并慢性心力衰竭（CHF）患者血浆微小RNA-423-5p(miRNA-423-5p)表达的影响及其与心功能之间的相关性。方法 纳入2021-04-01至2021-11-30就诊于解放军第九六〇医院的T2DM合并CHF患者50例为研究对象,分为达格列净组（n=25）和对照组（n=25）,达格列净组给予达格列净10 mg/d,对照组给予其他降糖药物,余治疗原则相同,治疗6个月。另纳入同一时期于本院健康体检的心功能正常者为健康人群组（n=25）。通过数字病历系统收集患者的基本资料,包括年龄、性别、吸烟史、高血压史、血压水平、体质指数（BMI）、血脂、血糖、肌酐（Cr）、氨基末端脑钠肽前体（NT-proBNP）、丙氨酸氨基转移酶（ALT）、天冬氨酸氨基转移酶（AST）、纽约心脏病协会（NYHA）心功能分级、心脏彩超、合并用药情况,并留取血液标本进行miRNA-423-5p的检测。治疗4周进行门诊随访,收集患者心功...     

纳米颗粒和外泌体靶向载药系统诊治动脉粥样硬化的机遇与挑战

动脉粥样硬化是一种慢性炎症性疾病,粥样斑块慢性聚集并沉积于大中型动脉内膜,导致严重的狭窄和血运障碍,引发组织器官缺血缺氧。纳米药物相对于传统药物在动脉粥样硬化治疗中因其具有独特的优势而广泛受到关注。本文重点综述几种纳米靶向颗粒（系统）和外泌体靶向载药系统在抗动脉粥样硬化研究中的应用,简述代表性纳米材料的合成过程,对其靶向性进行分析,并概述纳米药物的益处和内在挑战。尽管面临着一些需要解决和完善的挑战,但是纳米颗粒和外泌体靶向载药治疗的前景广阔,并有望将其推广应用于临床实践中。     

Reciprocal interactions between α2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat

Summary Interactions between a ₂-adrenoreceptor agonist and neuropeptide Y (NPY) binding sites have been studied in the rat medulla oblongata (MO) using biochemical binding techniques as well as quantitative autoradiography. Tritiated para-amino clonidine (³H-PAC; ₂-adrenoceptor agonist), idazoxan (³H-IDA; ₂-adrenoceptor antagonist) and iodinated neuropeptide Y (¹²⁵I-NPY) were used as radioligands. (1) Neuropeptide Y (NPY; 10^–8M) but not bovine pancreatic polypeptide (BPP) nor peptide YY (PYY 10nM) increased the K_D value of³H-PAC binding sites. However, intraventricular administration of a high dose of NPY (1.25nmol) did not change the³H-PAC binding characteristics in MO membrane preparations of these animals. (2) GTP 10^–4 lowered the affinity of³H-PAC binding. NPY (10 nM) had no additional effect, nor did NPYinfluence the GTP induced shift in potency of clonidine to displace³H-IDA from its binding sites. (3) In the autoradiographical experiments NPY (10nM) significantly reduced³H-PAC binding (2nM) in the nucleus tractus solitarius (NTS) area by 35%. (4) When clonidine, either given centrally in vivo (3.75nmol) or in vitro (10 nM) the binding of¹²⁵I-NPY was reduced (34 and 24%, respectively) in the NTS. When the monoamine receptors were irreversibly blocked in vivo by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ, 10 g i.e. 24h)¹²⁵I-NPY (0.5 nM) binding was increased by 137% in the NTS. This effect of EEDQ was prevented by pretreatment with the ₂-adrenoreceptor antagonist idazoxan.These results provide support for a direct intramembrane interaction between the ₂-receptor and the NPY receptor within the NTS and may be of importance in central cardiovascular regulation.